| P50 | author | Hongjun Song | Q46050928 |
| P2093 | author name string | Hong-Jun Song | |
| | Quan-Yong Luo | |
| | Zhong-Ling Qiu | |
| | Zhen-Kui Sun | |
| | Chen-Tian Shen | |
| | Wei-Jun Wei | |
| | Xin-Yun Zhang | |
| P2860 | cites work | Cancer statistics, 2015 | Q27860576 |
| | 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer | Q30367068 |
| | Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation | Q33394129 |
| | Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens | Q35215882 |
| | Normal FDG distribution patterns in the head and neck: PET/CT evaluation. | Q36056391 |
| | Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. | Q36266372 |
| | Frequency of Diabetes and Thyroid Autoantibodies in Patients with Type 1 Diabetes and Their Siblings | Q36936407 |
| | Serum thyroglobulin determination in thyroid cancer patients | Q37337519 |
| | Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level. | Q37823794 |
| | Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). | Q37932229 |
| | The role of 18F-FDG PET/CT in the follow-up of well-differentiated thyroid cancer with negative thyroglobulin but positive and/or elevated antithyroglobulin antibody | Q38712729 |
| | Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer | Q39261916 |
| | Association of established thyroid peroxidase autoantibody (TPOAb) genetic variants with Hashimoto's thyroiditis | Q40716036 |
| | Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT. | Q43278570 |
| | Sequential changes of serum antithyroglobulin antibody levels are a good predictor of disease activity in thyroglobulin-negative patients with papillary thyroid carcinoma | Q44212252 |
| | Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results. | Q46031990 |
| | The additive clinical value of 18F-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer who have isolated increased antithyroglobulin antibody levels | Q47395111 |
| | Serum thyroid autoantibodies in patients with idiopathic either acute or chronic urticaria | Q47892606 |
| | The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level. | Q51120965 |
| | I-131 SPECT/CT elucidates cryptic findings on planar whole-body scans and can reduce needless therapy with I-131 in post-thyroidectomy thyroid cancer patients. | Q53196205 |
| | Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level. | Q53198814 |
| | Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody. | Q53306759 |
| | Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. | Q53666999 |
| | Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma | Q57211224 |
| | Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome | Q67964874 |
| | Thyroid function and autoimmunity in pernicious anemia before and during cyanocobalamin treatment | Q71942725 |
| | Impact of previous thyroid autoimmune diseases on prognosis of patients with well-differentiated thyroid cancer | Q73650390 |
| | Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases | Q77321985 |
| | Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy | Q81920398 |
| | The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer | Q81926085 |
| | Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management | Q83089268 |
| | Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodies | Q83325415 |
| | [Use of 18F FDG-PET in patients with suspicion of recurrent differentiated thyroid cancer by elevated antithyroglobulin antibodies levels and negative ¹³¹I scan] | Q83445988 |
| | High recurrent rate of multicentric papillary thyroid carcinoma | Q84077085 |
| | Thyroglobulin antibody levels do not predict disease status in papillary thyroid cancer | Q87228478 |
| | Postoperative stimulated thyroglobulin of less than 1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive iodine ablation | Q87421724 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | papillary thyroid cancer | Q2292945 |
| | Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography | Q130273251 |
| P304 | page(s) | 2849 | |
| P577 | publication date | 2017-06-06 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Diagnostic Performance of 18F-FDG PET/CT in Papillary Thyroid Carcinoma with Negative 131I-WBS at first Postablation, Negative Tg and Progressively Increased TgAb Level | |
| P478 | volume | 7 | |